Call For Assay Proposals For The NINDS High Throughput Drug Screening Service Facility
Funding Contact(s): Jill Heemskerk, Ph.D.
Funding Categories: Translational Research
Brief Description:
The National Institute of Neurological Disorders and Stroke established a high throughput drug screening (HTS) facility at
Southern Research Institute in Birmingham, Alabama in 2002. This facility was established to provide an opportunity for
neurodegeneration researchers with robust and reproducible assays to have their assays tested against a collection of 100,000
compounds in a high throughput setting. Working closely with investigators, the facility adapts these assays into high throughput
formats and uses them to screen a collection of chemically diverse compounds.